This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
American Vanguard (AVD) Q2 Earnings and Sales Miss Estimates
by Zacks Equity Research
Unfavorable market conditions weigh on American Vanguard's (AVD) top line in the second quarter.
Koppers (KOP) Earnings Surpass Estimates, Sales Lag in Q2
by Zacks Equity Research
Koppers (KOP) sees record sales in its Railroad and Utility Products and Services segment on higher pricing and increased crosstie and utility poles volumes in Q2.
Interpreting Quaker Chemical (KWR) International Revenue Trends
by Zacks Equity Research
Explore how Quaker Chemical's (KWR) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Quaker Chemical's (KWR) Q2 Earnings and Sales Miss Estimates
by Zacks Equity Research
Lower selling prices and reduced volumes due to weaker end-market conditions weigh on Quaker Chemical's (KWR) top line in Q2.
Quaker Chemical (KWR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Quaker Chemical (KWR) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Quaker Chemical (KWR) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of -3.62% and 5%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Hawkins (HWKN) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Hawkins (HWKN) delivered earnings and revenue surprises of 36.63% and 0.62%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Blachem (BCPC) Tops Q2 Earnings Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of 3.16% and 2.97%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Quaker (KWR) Breaks Ground on New Manufacturing Plant in China
by Zacks Equity Research
The facility will play a significant part in Quaker's (KWR) global supply chain, strengthening the company's position as a market leader in industrial process fluids.
Is the Options Market Predicting a Spike in Quaker Chemical (KWR) Stock?
by Zacks Equity Research
Investors need to pay close attention to Quaker Chemical (KWR) stock based on the movements in the options market lately.
Quaker Chemical's (KWR) Q1 Earnings Beat Estimates, Sales Lag
by Zacks Equity Research
Lower selling prices and product mix as well as reduced volumes weigh on Quaker Chemical's (KWR) top line in Q1.
Understanding Quaker Chemical (KWR) Reliance on International Revenue
by Zacks Equity Research
Explore how Quaker Chemical's (KWR) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Quaker Chemical (KWR) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Quaker Chemical (KWR) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Quaker Chemical (KWR) Q1 Earnings Top Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of 6.09% and 4.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Ingevity (NGVT) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of 40.54% and 6.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Ashland (ASH) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Ashland (ASH) delivered earnings and revenue surprises of 6.72% and 0.13%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Quaker Chemical's (KWR) Earnings and Sales Beat Estimates in Q4
by Zacks Equity Research
Quaker Chemical (KWR) tops earnings estimates in Q4 despite lower selling prices and volumes.
Quaker Chemical (KWR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Quaker Chemical (KWR) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Quaker Chemical (KWR) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of 8.54% and 0.02%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Insights Into Quaker Chemical (KWR) Q4: Wall Street Projections for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Quaker Chemical (KWR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
Arcadium (ALTM) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Arcadium (ALTM) delivered earnings and revenue surprises of -5.56% and 17.04%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Quaker Chemical (KWR) Stock Rallies 32% in 3 Months: Here's Why
by Zacks Equity Research
Quaker Chemical's (KWR) rally is driven by robust financial performance, supported by a favorable earnings track record and propelled by strong sales in both the EMEA and Asia/Pacific regions.
Here's What Makes Koppers (KOP) Stock a Solid Choice Right Now
by Zacks Equity Research
Koppers (KOP) is a good investment opportunity with solid growth prospects and attractive valuation, as evidenced by its recent stock performance and earnings surprise history.
Here's Why You Should Hold Onto DuPont (DD) Stock for Now
by Zacks Equity Research
DuPont (DD) gains on its focus on growth though innovation, the Spectrum Plastics acquisition and productivity actions amid headwinds from soft demand in certain markets.
Here's Why You Should Add Olympic Steel (ZEUS) to Your Portfolio
by Zacks Equity Research
Olympic Steel (ZEUS) remained profitable in Q3 despite market challenges. The acquisition of Central Tube & Bar supports its growth strategy, enhancing market presence.